|
| |
|
|
PD0332991
|
|
CAS NO
571190-30-2
Formula
C24H29N7O2
Solubility
DMSO
Storage
at -20℃ 2 years
Weight
447.53
Biological Activity
PD0332991 is an orally available pyridopyrimidine-derived cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity. This compound is a highly specific inhibitor of cyclindependent kinase 4 (Cdk4) (IC50, 0.011 μmol/L) and Cdk6 (IC50, 0.016 μmol/L), having no activity against a panel of 36 additional protein kinases. [1]
References
[1] Fry DW et al.Mol Cancer Ther. 2004 Nov;3(11):1427-38
|
| | |
|